Skip to main content
. 2017 Mar 8;22(3):433. doi: 10.3390/molecules22030433

Figure 3.

Figure 3

LPS pretreatment leads to increased level of cardiac NO and O2•−. Figure shows cardiac peroxynitrite precursor nitric oxide (NO) (A) and superoxide (O2) (B) levels 24 h after in vivo 0.5 mg/kg lipopolysaccharide (LPS) treatment. Values are expressed as mean ± S.E.M. (n = 7–12). # p < 0.05 vs. control, unpaired t-test.